Clinical trial
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
NCT04190420 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
- Lead sponsor
- Karolinska Institutet
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 1, 2018
- Completion date
- December 31, 2030
- Enrollment
- 310 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diastolic dysfunction, heart failure, hypertension, hypertensive heart disease